AAV-2 CMV Expression System - 1 kit

(0 review)

£ 1,246.10 1246.1000000000001 GBP £ 1,246.10 VAT Excluded

1,466.00 € VAT Excluded

Not Available For Sale

    This combination does not exist.

    Terms and Conditions
    30-day money-back guarantee
    Shipping: 2-3 Business Days

    • Complete Expression System contains packaging plasmids, expression vector and GFP control vector for packaging of recombinant AAV serotype 2
    • pHelper plasmid contains required E2A, E4, and VA RNA adenoviral genes; eliminates the need for a helper adenovirus
    • Cloning capacity of expression vector = 3 kb

    The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells.

    Recent Product Citations

    1. Tseng, S.J. et al. (2022). An acid degradable, lactate oxidizing nanoparticle formulation for non-small cell lung cancer virotherapy. Nano Today. doi: 10.1016/j.nantod.2022.101582.
    2. Hsieh, C.C. et al. (2022). Macrophage Distribution Affected by Virus-Encoded Granulocyte Macrophage Colony Stimulating Factor Combined with Lactate Oxidase. ACS Omega. doi: 10.1021/acsomega.2c03213.
    3. Kuwabara, Y. et al. (2020). Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload. Commun Biol. 3(1):434. doi: 10.1038/s42003-020-01164-0.
    4. Okubo, Y. et al. (2019). Store-operated Ca2+ entry-dependent Ca2+ refilling in the endoplasmic reticulum in astrocytes. Biochem Biophys Res Commun. pii: S0006-291X(19)32326-5. doi: 10.1016/j.bbrc.2019.12.006.
    5. Robert, M.A. et al. (2018). Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections. Hum Gene Ther. 29(4):452-466. doi: 10.1089/hum.2017.101.